EXAM #1: ANS PHARMACOLOGY - CHOLINERGICS Flashcards

1
Q

What is a direct acting cholinomimetics?

A

Drugs that bind directly to and activate muscarinic or nicotinic cholinoceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a indirect acting cholinomimetics?

A

Drugs that produce their effects by inhibiting AChE i.e. preventing the destruction of endogenous ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two classes of indirect acting cholinomimetics? What are their basic clinical and commerical applications?

A
  • Reversible= used to treat Alzheimer’s Disease or Myasthenia Gravis
  • Irreversible= Organophosphates, commerical insecticides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the different types of direct-acting cholinomimetics?

A

1) Choline esters
2) Natural alkaloids
3) Synthetic analogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the choline esters. Generally, what type of drug are these?

A
  • Acetylcholine
  • Methacholine
  • Carbachol
  • Bethanechol

These are all “choline esters,” which are direct cholinoceptor agonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe ACh’s: 1) susceptibility to cholinesterase, 2) muscarinic action, and 3) nicotinic action.

A

1) High susceptibility to cholinesterase

2) Equally high muscarinic and nicotinic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Methacholine’s: 1) susceptibility to cholinesterase, 2) muscarinic action, and 3) nicotinic action.

A

1) Low susceptibility to cholinesterase
2) High muscarinic action (greater than ACh)
3) Low nicotinic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe Carbachol’s: 1) susceptibility to cholinesterase, 2) muscarinic action, and 3) nicotinic action.

A

1) NO susceptibility to cholinesterase
2) Moderate muscarinic action
3) Moderately high nicotinic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe Bethanechol’s: 1) susceptibility to cholinesterase, 2) muscarinic action, and 3) nicotinic action.

A

1) NO susceptibility to cholinesterase
2) Moderate muscarinic action
3) NO nicotinic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the cardiovascular effects of the choline esters?

A
  • Hypotension from direct vasodilation
  • Bradycardia
  • Slowed conduction/ prolonged refractory period of AV node
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the gastrointestinal effects of the choline esters? What symptoms seen with choline esters?

A
  • Increased tone and contractility of the gut
  • Increased acid secretion

Nausea, vomiting, diarrhea, and cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the genitourinary effects of the choline esters?

A
  • Increased bladder motility and relaxation of sphincter resulting in involuntary urination
  • Little or NO effect on UTERUS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the ocular effects of the choline esters?

A
  • Miosis (sphincter m.)

- Decreased intraocular pressure and accomodation (ciliary m.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the respiratory effects of the choline esters?

A

Bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the effects of choline esters on glands?

A

Increased secretory activity resulting in:

  • Salivation
  • Lacrimation
  • Sweating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does acetylcholine need to be administered? Why?

A

IV b/c it is rapidly destroyed by AChE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the effects of ACh on the cardiovascular system at low doses vs. high doses?

A

Low=

  • Vasodilation
  • Decreased TPR b/c of M3 receptor activation on vascular endothelium
  • -> “Reflex tachycardia”

High=

  • Bradycardia
  • Decreased AV conduction
  • Negative ionotope
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the nicotinic effects of ACh?

A

None–does NOT penetrate fat surrounding skeletal muscle and ANS ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the clinical uses of ACh?

A

B/c of rapid degradation, clinical use is limited, but it can be used for:

1) Eye surgery for short-lasting miosis
2) Provocation test in coronary angiography

Provocation test assists in the diagnosis of coronary vasospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the respiratory effects of ACh administration?

A

1) Bronchoconstriction
2) Increased bronchial secretion

Thus, ACh should NOT be given to ASTHMATICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the clinical use of methacholine?

A

Diagnosis of bronchiolar hypersensitivity

This is called a “methacholine challenge”–>M3 activation leads to transient bronchoconstriction patients with bronchiolar hypersensitivity at much lower doses than normal population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does Methacholine differ from ACh?

A

Longer half-life b/c of methyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the clinical cuse of Carbachol?

A

Treatment of Glaucoma; it contracts the ciliary muscle, which:

1) Enlarges canal of Schlemm
2) Increases drainage of aqueous humor
3) Decreases intraocular pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What receptors are activated by therapeutic doses of Carbachol?

A

BOTH nicotinic and muscarinic cholinoreceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the danger associated with high doses of Carbachol?

A

May induce cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the clinical indications for Bethanechol?

A

1) Gastric atony
2) Gastric emptying abnormalities
3) Urinary retention (w/out obstruction)

Bethanechol increases Lower Esophageal Sphincter (LES) tone; this can reduce symptoms of reflux s/p vagotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the predominate Gu and GI effects of Bethanechol? Drug interaction with which type of receptor mediates these effects?

A

GU=

  • Increased detrusor tone
  • Decreased outlet resistance of internal sphincter

GI= increased motility and secretion

M3 receptor mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the two direct acting muscarininc alkaloids?

A

Muscarine

Pilocarpine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the symptoms of muscarine poisoning?

A
  • Salivation, lacrimation, and sweating initially
  • Abdominal pain, nausea, diarrhea, blurred vision, and dyspnea

Effects typically subside within 2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the clinical uses of Pilocarpine?

A
  • Glaucoma- this is the drug of choice (topically)
  • Xerostomia (orally)
  • Test on autonomic state/ PNS dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What effects of Pilocarpine predominate? What receptor type are these effects mediated by?

A

Opthalmic (M3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What the mechanism of action of Pilocarpine on the eye?

A

1) Contracts sphincter muscle to produce MIOSIS
2) Contracts ciliary m. to free entrance into Canal of Schlemm (narrow angle Glaucoma)
3) Enhances tone of trabecular network (wide angle glaucoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the contraindciations to direct-acting cholinoceptor agonists?

A

1) Peptic ulcers
2) GI tract disorders
3) Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What drugs interact with direct-acting cholinoceptor agonists?

A

Drugs with antimuscarinic properties:

  • Quinidine (antiarrhythmic)
  • Procainamide (antiarrhythmic)
  • Tricyclic antidepressants

All can block the intended effects of cholinoceptor agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the two nicotinic alkaloids?

A

Nicotine
Succinylcholine

These are direct acting nicotinic receptor agonists. Note that b/c of dramatic long term receptor activation, Succinylcholine function as a nicotinic receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the actions of nicotine on Nm receptors?

A
  • Skeletal muscle contraction
  • Fasiculations/ spasm
  • Depolarizing blockade (similar to succinylcholine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Generally, what is the action of nicotine on Nn receptors?

A

Stimulation of BOTH SNS and PNS post-ganglionic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the action of nicotine on Nn subtype receptors in the heart?

A

Increased heart rate

39
Q

What is the action of nicotine on Nn subtype receptors in the vascular system?

A

Peripheral vasoconstriction

40
Q

What is the action of nicotine on Nn subtype receptors in the GI tract?

A

Increased gut motility and secretion

41
Q

What is the action of nicotine on Nn subtype receptors in the carotid bodies?

A

Increased respiratory rate

42
Q

What is the action of nicotine on Nn subtype receptors in the medullary emetic chemoreceptors?

A

Nausea and vomiting

43
Q

What is the clinical indication for nicotine prescription?

A

To assist with smoking cessation

44
Q

List the reversible cholinesterase inhibitors.

A
Edrophonium 
Neostigmine 
Pyridostigmine 
Phyostigmine 
Donepezil 
Tacrine
45
Q

What is the important characteristic of Edrophonium?

A

Short-acting

46
Q

What is the clinical use of Edrophonium?

A

Diagnosis of Myasthenia Gravis

*****It can be difficult to differentiate the symptoms/ etiology of myasthenia gravis. Blocking AChE leads to the specific improvement of MG symptoms and can thus be useful diagnostically.

47
Q

What is are important characteristics of Neostigmine and Pyridostigmine?

A
  • Quaternary amines= no CNS entry
  • Intermediate-acting

**Inability to penetrate the CNS keeps the action of these drugs confined to the periphery hence their utility in treating MG.*

48
Q

What are the clinical uses of Neostigmine and Pyridostigmine?

A

These are the standard AChE inhibitors used to treat Myasthenia Gravis. Other uses include:

1) Ileus
2) Urinary retention
4) Reversal of non-depolarizing NM blockers

49
Q

What are the important characteristic of Physostigmine?

A
  • Tertiary amine= ENTERS CNS

- Intermediate acting

50
Q

What are the clinical uses of Physostigmine?

A
  • Glaucoma

- Antidote in atropine overdose

51
Q

What is the important characteristic of Donepezil and Tacrine?

A

Lipid soluble i.e. enters the CNS

52
Q

What is the clinical use of Donepezil and Tacrine?

A

Alzheimer’s disease

There is a deficiency in intact cholinergic neurons in AD; thus these drugs, which DO cross the BBB are used.

53
Q

What are the important characteristics of Organophosphates?

A

1) Lipid-soluble
2) Long-acting
3) Irreversible inhibitors of AChE

54
Q

What are the clinical uses for the Organophosphates?

A

1) Glaucoma
2) Insecticide
3) Nerve gas

55
Q

What is the mnemonic to remember the symptoms of cholinesterase inhibitor intoxication?

A

DUMBBELSS

D= Diarrhea 
U= Urination
M= Miosis 
B= Bronchoconstriction
B= Bradycardia 
E= Excitement 
L= Lacrimation 
S= Sweating 
S= Salivation
56
Q

List the muscarinic receptor antagnoists.

A

Atropine
Ipratropium
Benztropine

57
Q

What are the characteristics of atropine?

A
  • Tertiary amine; thus, it enters the CNS (but not readily at therapeutic doses)
  • Competes with ACh at M receptors
  • Does NOT distinguish between M1, M2, and M3 receptors
58
Q

What are the pharmacologic effects of atropine?

A

1) Decreased secretions
2) Mydriasis and cycloplegia
3) Hyperthermia
4) Tachycardia
5) Sedation
6) Urinary retention and constipation
7) Behavioral excitation and hallucinations

*****Note that these effects are listed in order of increasing dose.

59
Q

What drug will completely counteract peripheral vasodilation caused by choline esters?

A

Atropine

60
Q

Does atropine effect blood pressure when given alone?

A

NO

This is due to lack of significant cholinergic innervation most vascular beds

61
Q

What are the indications for atropine?

A
  • Antispasmodic
  • Antisecretory
  • Management of AChE inhibitor overdose
  • Antidiarrheal
  • Ophthalmology
  • Prevention of vagal reaction e.g. in pericardiocentesis
62
Q

What drug can be used to counteract acute intoxication of atropine?

A

Physostigmine

63
Q

What are the clinical uses of Ipratropium?

A

1) First line therapy for COPD

2) Asthma (2nd line)

64
Q

What are the properties of Ipratropium?

A
  • Nonselective muscarinic antagonist
  • Mainly acts on bronchial SMC/ glandular M3 receptors when inhaled
  • Quaternary amine= no CNS effects
65
Q

What are the effects of Ipratropium?

A

1) Decreased bronchoconstriction

2) Decreased bronchial secretions

66
Q

What are the clinical uses of Benztropine?

A
  • Parkinson’s Disease (2nd or 3rd line therapy)

- PD secondary to an antipsychotic medication

67
Q

What are the properties of Benztropine?

A
  • Tertiary amine= CNS absorption

- Acts on muscarinic receptors in the brain

68
Q

What are the effects of Benztropine?

A

1) Re-establishment of DA-ACh balance in patients with PD
- Decreased GI/GU secretions and motility
- Increased HR

69
Q

What are the two nicotinic receptor antagonists?

A

Hexamethonium

Mecamylamine

70
Q

What are the pharmacologic effects of nicotinic receptor antagonists?

A
  • Reduce the predominant ANS tone
  • Prevent baroreceptor reflex changes in HR

**Most are no longer available clinically b/c of toxicity

71
Q

What is the effect of nicotinic receptor antagonists on the arterioles? Which system (PNS or SNS) is being antagonized?

A

SNS

- Vasodilation and hypotension

72
Q

What is the effect of nicotinic receptor antagonists on the veins? Which system (PNS or SNS) is being antagonized?

A

SNS

  • Dilation
  • Decreased venous return
  • Decreased CO
73
Q

What is the effect of nicotinic receptor antagonists on the heart? Which system (PNS or SNS) is being antagonized?

A

PNS

- Tachycardia

74
Q

What is the effect of nicotinic receptor antagonists on the iris? Which system (PNS or SNS) is being antagonized?

A

PNS

- Mydriasis

75
Q

What is the effect of nicotinic receptor antagonists on the ciliary muscle? Which system (PNS or SNS) is being antagonized?

A

PNS
- Cycloplegia

Cycloplegia is the paralysis of the ciliary muscle of the eye, which results in a loss of accommodation.

76
Q

What is the effect of nicotinic receptor antagonists on the GI tract? Which system (PNS or SNS) is being antagonized?

A

PNS

  • Decreased tone and motility
  • Costipation
77
Q

What is the effect of nicotinic receptor antagonists on the bladder? Which system (PNS or SNS) is being antagonized?

A

PNS

- Urinary retention

78
Q

What is the effect of nicotinic receptor antagonists on the salivary glands? Which system (PNS or SNS) is being antagonized?

A

PNS

- Xerostomia

79
Q

What is the effect of nicotinic receptor antagonists on the sweat glands? Which system (PNS or SNS) is being antagonized?

A

SNS
- Anhidrosis

Ahidrosis is the abnormal lack of a sweating response.

80
Q

What is the non-depolarizing neuromuscular blocking agent?

A

D-tubocurarine

81
Q

What is the depolarizing neuromuscular blocking agent?

A

Succinylcholine

82
Q

What are the neuromuscular blocking drugs clinically used for?

A

Used as adjuncts during general anesthesia to:

1) Facilitate tracheal intubation
2) Optimize surgical conditions while ensuring adequate ventilation

83
Q

What is D-tubocurarine’s mechanism of action? What is the difference between small and large doses?

A

Prevention of ion channel opening when bound to the Nm receptor

  • Low dose= compete with ACh
  • High dose= enters the Nm channel pore
84
Q

What is phase 1 of depolarizing neuromuscular blocking agents?

A

1) Drug binds Nm receptor causing depolarization
2) Persistent depolarization leads to paralysis

*****Note that this effect can be augmented by the administration of AChE inhibitors

85
Q

What is Phase 2 blockade of depolarizing neuromuscular blocking agents?

A

Repolarized occurs but the receptor is “desensitized” and not easily depolarized again

86
Q

In what sequence do muscles respond Succinylcholine administration? In what order do they recover?

A
  • Larger muscles are more resistant than smaller ones
  • Diaphragm responds last
  • Larger muscles recover first
87
Q

Aside from facilitating airway management, what else can neuromuscular blocking agents be used for?

A

Treatment of convulsions

Note that these agents DO NOT enter the CNS and thus only decrease the MUSCULAR manifestations of a seizure

88
Q

What are the side effects of the neuromusclar blockers?

A
  • Hypotension
  • Hyperkalemia
  • Increased intraocular pressure
  • Increase intragastric pressure
  • Muscle pain
89
Q

Why does hypotension follow neuromuscular blocker administration? What can be given to prevent this?

A
  • Tubocurarine can produce systemic histamine release that results in hypotension
  • Anti-histamines can prevent this effect
90
Q

Describe the structure of the choline esters. What is clinically important about their structure?

A

All are “cationic quaternary ammonium compounds”

*****Thus, all are INSOLUBLE in lipids and DO NOT enter the CNS

91
Q

Which two choline esters have an extended half-life compared to ACh? What is the structural basis for this difference?

A

1) Methacholine
2) Bethanechol

BOTH have a longer half life b/c of the addition of a methyl group

92
Q

Outline the management of cholinesterase inhibitor intoxication.

A

1) Symptom management including:
- Airway support
- Cardiovascular support
2) Antidote= ATROPINE
3) PRALIDOXIM (2-PAM)= regeneration of AChE

Atropine is a a muscarinic receptor antagonist that can block M receptors from high ACh conentrations. AChE inhibitors phosphorylate AChE. 2-PAM reverses that phosphorylation.

93
Q

What is Myasthenia Gravis?

A

NM disorder caused by autoimmune attack of the ACh receptor on post-junctional endplate, which causes:

  • Weakness
  • Fagitability of skeletal muscle

Fgitability is an increased susceptibility to fatigue.

94
Q

What is the difference between the mechanism of action of a depolarizing vs. a non-depolarizing NM-blocking agent?

A

Non-depolarizing= prevents Nm Na+ channel opening

Depolarizing= prevents Nm Na+ channel opening